Welcome to CDC stacks | Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi - 24308 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
Filetype[PDF-198.75 KB]


Details:
No Related Documents.
You May Also Like:
  1. Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy
    Personal Author:
    Gessner, Bradford D.; Feikin, Daniel R.;
    Published:
    Apr 13 2014
    Source:
    Vaccine. 32(26):3133-3138.
    Description:
    Traditionally, vaccines have been evaluated in clinical trials that establish vaccine efficacy (VE) against etiology-confirmed disease outcomes, a measure important for licensure. Yet, VE does not reflect a vaccine's public health impact because...
    File Type:
    Filetype[PDF - 286.35 KB]
  2. The impact of new vaccine introduction on immunization and health systems: A review of the published literature
    Personal Author:
    Hyde, Terri B.; Dentz, Holly; Wang, Susan A.; Burchett, Helen E.; Mounier-Jack, Sandra; Mantel, Carsten F.;
    Corporate Author:
    The New Vaccine Introduction Impact Published Literature Working Group
    Published:
    Aug 29 2012
    Source:
    Vaccine. 30(45):6347-6358.
    Description:
    We conducted a systematic review of the published literature to examine the impact of new vaccine introduction on countries' immunization and broader health systems. Six publication databases were searched using 104 vaccine and health system-related ...
    File Type:
    Filetype[PDF - 996.33 KB]
  3. Prevention and control of haemophilus influenzae type b disease : recommendations of the advisory committee on immunization practices (ACIP)
    Personal Author:
    Briere, Elizabeth C.; Rubin, Lorry; Moro, Pedro L.; Cohn, Amanda C.; Clark, Thomas A.; Messonnier, Nancy E.;
    Corporate Author:
    United States. Advisory Committee on Immunization Practices.. National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases..
    Published:
    February 28, 2014
    Source:
    MMWR Recomm Rep. 2014 Feb 28;63(RR-01):1-14.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 63, RR-01
    Description:
    This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of Haemophilus influenzae type b (Hib) disease in the United States. As a comprehensive summary of...
    Status:
    current
    File Type:
    Filetype[PDF - 642.56 KB]
  4. Cost-Effectiveness of Haemophilus inuenzae Type b Conjugate Vaccine in Low- and Middle-Income Countries: Regional Analysis and Assessment of Major Determinants
    Personal Author:
    Griffiths, Ulla Kou; Clark, Andrew; Hajjeh, Rana;
    Published:
    Jul 2013
    Source:
    J Pediatr. 163(1 Suppl):S50-S59.e9
    Description:
    Objectives : To estimate the cost-effectiveness of Haemophilus influenzae type b (Hib) conjugate vaccine in low-and middle-income countries and identify the model variables, which are most important for the result. : Study design : A static decision ...
    File Type:
    Filetype[PDF - 863.12 KB]
  5. Use of vaccines as probes to define disease burden
    Personal Author:
    Feikin, Daniel R; Scott, J Anthony G; Gessner, Bradford D;
    Published:
    Feb 17 2014
    Source:
    Lancet. 383(9930):1762-1770.
    Description:
    Vaccine probe studies have emerged in the past 15 years as a useful way to characterise disease. By contrast, traditional studies of vaccines focus on defining the vaccine effectiveness or efficacy. The underlying basis for the vaccine probe approach...
    File Type:
    Filetype[PDF - 203.93 KB]